hat
Wi li gen pwoblèm. flè-tèt yo ak fèy nan kèk tansyon chanv endistriyèl pouvwa gen yon sous solid nan CBD (pwoblèm legal malgre), men chanv se pa gen okenn vle di yon sous pi bon nan cannabidiol. Endistriyèl chanv tipikman gen lwen mwens cannabidiol pase Cannabis CBD ki rich. Gwo kantite lajan nan chanv endistriyèl yo oblije ekstrè yon ti kantite CBD, kidonk ogmante risk pou yo kontaminan toksik paske chanv se yon "bio-aku" ki trase metal lou soti nan tè a. Single-molekil CBD sentetiz nan yon laboratwa oswa extrait ak rafine soti nan endistriyèl chanv manke kritik tèrpèn medsin ak cannabinoïdes segondè yo te jwenn nan tansyon Cannabis. Konpoze sa yo kominike avèk CBD ak THC amelyore benefis ki ka geri yo.
eng
Yes it does matter. The flower-tops and leaves of some industrial hemp strains may be a viable source of CBD (legal issues notwithstanding), but hemp is by no means an optimal source of cannabidiol. Industrial hemp typically contains far less cannabidiol than CBD-rich cannabis. Huge amounts of industrial hemp are required to extract a small amount of CBD, thereby raising the risk of toxic contaminants because hemp is a “bio-accumulator” that draws heavy metals from the soil. Single-molecule CBD synthesized in a lab or extracted and refined from industrial hemp lacks critical medicinal terpenes and secondary cannabinoids found in cannabis strains. These compounds interact with CBD and THC to enhance their therapeutic benefits.